Renaissance Technologies
IPSC icon

Renaissance Technologies’s Century Therapeutics IPSC Stock Holding History

Renaissance Technologies’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
1,257,700
+350,873
+39% +$802K ﹤0.01% 1724
2026
Q1 		$2.05M Sell
906,827
-442,373
-33% -$930K ﹤0.01% 1879
2025
Q4 		$1.34M Sell
1,349,200
-1,237,700
-48% -$755K ﹤0.01% 2107
2025
Q3 		$1.29M Buy
2,586,900
+564,400
+28% +$304K ﹤0.01% 2351
2025
Q2 		$1.13M Buy
2,022,500
+837,182
+71% +$449K ﹤0.01% 2450
2025
Q1 		$564K Sell
1,185,318
-17,567
-1% -$13.2K ﹤0.01% 2694
2024
Q4 		$1.21M Buy
1,202,885
+714,685
+146% +$973K ﹤0.01% 2380
2024
Q3 		$835K Buy
488,200
+322,700
+195% +$632K ﹤0.01% 2550
2024
Q2 		$422K Buy
165,500
+9,500
+6% +$30K ﹤0.01% 2774
2024
Q1 		$652K Buy
156,000
+36,800
+31% +$156K ﹤0.01% 2750
2023
Q4 		$396K Buy
119,200
+31,500
+36% +$57.4K ﹤0.01% 2875
2023
Q3 		$175K Buy
87,700
+20,400
+30% +$54.3K ﹤0.01% 3127
2023
Q2 		$213K Sell
67,300
-85,801
-56% -$277K ﹤0.01% 3278
2023
Q1 		$531K Buy
153,101
+48,001
+46% +$211K ﹤0.01% 2855
2022
Q4 		$539K Buy
+105,100
New +$992K ﹤0.01% 2917

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Renaissance Technologies's IPSC Position: Q2 2026 in Review

Renaissance Technologies increased its Century Therapeutics (IPSC) stake by 39% in Q2 2026, buying an estimated $802K and bringing the position to 1,257,700 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Renaissance Technologies first reported a position in IPSC in Q4 2022 and has held it in 15 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Renaissance Technologies held 1,257,700 shares of Century Therapeutics worth $3.08M as of Q2 2026.
  • Renaissance Technologies bought 350,873 Century Therapeutics shares in Q2 2026, an estimated $802K.
  • Century Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1724 holding.
  • Renaissance Technologies first reported a position in Century Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.